Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa

Antonio Siniscalchi, Luca Gallelli, Nicola B. Mercuri, Guido Ferreri Ibbadu, Giovambattista De Sarro

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Many papers documented that Parkinson's disease (PD) patients treated with levodopa (l-dopa) shows elevated plasma homocysteine (Hcy) levels. Several lifestyle factors are able to influence plasma Hcy levels. We review the evidence that l-dopa therapy is related with an increase in plasma Hcy levels and that several behaviours could be able to cause changes in plasma Hcy concentrations. Therefore, there are reasons to suggest that a healthy lifestyle lowering Hcy may prevent this potential iatrogenic complication during l-dopa therapy. Moreover, at present, no controlled prospective studies have evaluated this phenomenon.

Original languageEnglish
Pages (from-to)11-16
Number of pages6
JournalNutritional Neuroscience
Volume9
Issue number1-2
DOIs
Publication statusPublished - Feb 2006

Fingerprint

L-dopa
homocysteine
Levodopa
Homocysteine
lifestyle
Life Style
therapeutics
Parkinson disease
prospective studies
Parkinson Disease
Prospective Studies
Therapeutics

Keywords

  • Behaviours
  • Coffee
  • Homocysteine
  • Parkinson's disease patients
  • Smoke
  • Vitamin

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Neuroscience(all)
  • Food Science

Cite this

Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa. / Siniscalchi, Antonio; Gallelli, Luca; Mercuri, Nicola B.; Ibbadu, Guido Ferreri; De Sarro, Giovambattista.

In: Nutritional Neuroscience, Vol. 9, No. 1-2, 02.2006, p. 11-16.

Research output: Contribution to journalArticle

Siniscalchi, Antonio ; Gallelli, Luca ; Mercuri, Nicola B. ; Ibbadu, Guido Ferreri ; De Sarro, Giovambattista. / Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa. In: Nutritional Neuroscience. 2006 ; Vol. 9, No. 1-2. pp. 11-16.
@article{db47a9bff77a4aa78279c29fe972af94,
title = "Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa",
abstract = "Many papers documented that Parkinson's disease (PD) patients treated with levodopa (l-dopa) shows elevated plasma homocysteine (Hcy) levels. Several lifestyle factors are able to influence plasma Hcy levels. We review the evidence that l-dopa therapy is related with an increase in plasma Hcy levels and that several behaviours could be able to cause changes in plasma Hcy concentrations. Therefore, there are reasons to suggest that a healthy lifestyle lowering Hcy may prevent this potential iatrogenic complication during l-dopa therapy. Moreover, at present, no controlled prospective studies have evaluated this phenomenon.",
keywords = "Behaviours, Coffee, Homocysteine, Parkinson's disease patients, Smoke, Vitamin",
author = "Antonio Siniscalchi and Luca Gallelli and Mercuri, {Nicola B.} and Ibbadu, {Guido Ferreri} and {De Sarro}, Giovambattista",
year = "2006",
month = "2",
doi = "10.1080/10284150600583446",
language = "English",
volume = "9",
pages = "11--16",
journal = "Nutritional Neuroscience",
issn = "1028-415X",
publisher = "Maney Publishing",
number = "1-2",

}

TY - JOUR

T1 - Role of lifestyle factors on plasma homocysteine levels in Parkison's disease patients treated with levodopa

AU - Siniscalchi, Antonio

AU - Gallelli, Luca

AU - Mercuri, Nicola B.

AU - Ibbadu, Guido Ferreri

AU - De Sarro, Giovambattista

PY - 2006/2

Y1 - 2006/2

N2 - Many papers documented that Parkinson's disease (PD) patients treated with levodopa (l-dopa) shows elevated plasma homocysteine (Hcy) levels. Several lifestyle factors are able to influence plasma Hcy levels. We review the evidence that l-dopa therapy is related with an increase in plasma Hcy levels and that several behaviours could be able to cause changes in plasma Hcy concentrations. Therefore, there are reasons to suggest that a healthy lifestyle lowering Hcy may prevent this potential iatrogenic complication during l-dopa therapy. Moreover, at present, no controlled prospective studies have evaluated this phenomenon.

AB - Many papers documented that Parkinson's disease (PD) patients treated with levodopa (l-dopa) shows elevated plasma homocysteine (Hcy) levels. Several lifestyle factors are able to influence plasma Hcy levels. We review the evidence that l-dopa therapy is related with an increase in plasma Hcy levels and that several behaviours could be able to cause changes in plasma Hcy concentrations. Therefore, there are reasons to suggest that a healthy lifestyle lowering Hcy may prevent this potential iatrogenic complication during l-dopa therapy. Moreover, at present, no controlled prospective studies have evaluated this phenomenon.

KW - Behaviours

KW - Coffee

KW - Homocysteine

KW - Parkinson's disease patients

KW - Smoke

KW - Vitamin

UR - http://www.scopus.com/inward/record.url?scp=33745953159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745953159&partnerID=8YFLogxK

U2 - 10.1080/10284150600583446

DO - 10.1080/10284150600583446

M3 - Article

C2 - 16910165

AN - SCOPUS:33745953159

VL - 9

SP - 11

EP - 16

JO - Nutritional Neuroscience

JF - Nutritional Neuroscience

SN - 1028-415X

IS - 1-2

ER -